Oral Clinical Nutrition Market to Grow with a CAGR of 5.68% through 2030

Rising incidence of chronic diseases, an increasing focus on patient-centric care and the growing prevalence of malnutrition are expected to drive the growth of Global Oral Clinical Nutrition Market in the forecast period, 2026-2030.

According to TechSci Research report, “Oral Clinical Nutrition Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030F” the Global Oral Clinical Nutrition Market stood at USD 15.89 billion in 2024 and is anticipated to grow with a CAGR of 5.68% in the forecast period through 2030. This can be ascribed to rising incidence of chronic diseases, and an increasing focus on patient-centric care. Additionally, the growing prevalence of malnutrition and related conditions such as sarcopenia and cachexia will propel the growth of Oral Clinical Nutrition Market.

The global oral clinical nutrition market is expected to experience significant growth in the coming years due to several factors. These include an aging population, rising prevalence of chronic diseases, increasing awareness of the benefits of oral clinical nutrition products, technological advancements in product development, and growing demand for personalized nutrition. Additionally, the COVID-19 pandemic has highlighted the importance of maintaining good health, which has led to an increase in demand for nutritional supplements and products that can boost immunity and improve overall health. The market is also expected to benefit from the expansion of healthcare infrastructure in emerging economies, as well as favorable government initiatives and policies that support the use of nutritional supplements to prevent and manage disease.

The global oral clinical nutrition market growth is likely to be hampered by the increasing competition from new entrants, rising concerns about the safety and efficacy of nutritional supplements, and regulatory changes that could impact the market. Additionally, economic uncertainties and supply chain disruptions caused by events such as the COVID-19 pandemic could continue to pose challenges for manufacturers and patients alike. Companies will need to remain innovative, flexible, and responsive to changing market conditions to remain competitive and meet the evolving needs of patients.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Oral Clinical Nutrition Market.”

Global Oral Clinical Nutrition Market can be segmented by indication, by distribution channel, by regional distribution and company.

Based on Indication, ​Chronic kidney disease (CKD) is emerging as the fastest-growing indication within the global oral clinical nutrition market, driven by a convergence of epidemiological, clinical, and healthcare system factors. Globally, CKD affects over 800 million individuals, accounting for more than 10% of the population. The increasing prevalence of CKD is attributed to factors such as aging populations, rising incidences of diabetes and hypertension, and environmental challenges like climate change-induced heat stress and water salinity.​ CKD patients often experience protein-energy wasting, electrolyte imbalances, and metabolic acidosis, necessitating specialized nutritional interventions. Oral clinical nutrition products tailored for CKD patients are formulated to address these specific needs, providing controlled levels of protein, phosphorus, potassium, and sodium.

Based on Region, The Asia-Pacific region is experiencing the fastest growth in the global oral clinical nutrition market due to a combination of demographic trends, economic development, and evolving healthcare priorities. One of the most prominent factors contributing to this rapid expansion is the region's aging population. Countries such as Japan, China, and South Korea are seeing significant increases in elderly demographics, which correlates with a rising burden of chronic illnesses and age-related nutritional deficiencies. This has led to a greater need for clinical nutritional interventions to support disease management and improve the quality of life for older adults. Furthermore, consumer behavior is shifting, particularly in urban areas where awareness of nutrition and preventive healthcare is more pronounced. The proliferation of e-commerce platforms has also made clinical nutrition products more accessible to a wider population. As a result, the Asia-Pacific region is expected to continue expanding at a strong pace, making it a critical area of focus for global clinical nutrition companies. This dynamic growth underscores the increasing importance of the region in shaping the future of the oral clinical nutrition market.

Major companies operating in Global Oral Clinical Nutrition Market are:

• Abbott Laboratories, Inc.
• Pfizer, Inc.
• Bayer AG
• Nestle SA
• GlaxoSmithKline plc.
• Baxter International Inc.
• Otsuka Holdings, Co. Ltd.
• Baxter International Inc.
• Victus, Inc.
• Danone SA(Nutricia)

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global oral clinical nutrition market is experiencing significant growth due to several trends, including the increasing prevalence of chronic diseases and the aging population. With a greater understanding of the role of nutrition in preventing and managing chronic diseases, demand for oral clinical nutrition products has surged. The market is also witnessing a trend towards more specialized and customized products, as well as a greater focus on natural and organic ingredients. However, the market faces several challenges, including the lack of reimbursement for oral nutrition products in many countries, complex regulatory requirements, and a lack of awareness about the benefits of oral clinical nutrition. Despite these challenges, drivers such as the growing importance of e-commerce and direct-to-consumer sales channels, along with the rising demand for preventative healthcare and nutrition, are expected to fuel continued growth in the global oral clinical nutrition market in the coming years.” said Mr. Karan Chechi, Research Director of TechSci Research, a research based global management consulting firm.

“Oral Clinical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Alzheimer’s, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others), By Distribution Channel (Direct Sales v/s Indirect Sales), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Oral Clinical Nutrition Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Oral Clinical Nutrition Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com